计划CT影像组学预测局部晚期宫颈癌放疗疗效与血液学毒性:一项回顾性队列研究
在湘雅医院257例2014至2017年接受调强放疗的局部晚期宫颈癌患者中,从计划CT提取影像组学特征预测完全缓解、5年总生存、贫血和白细胞减少;临床病理参数联合影像组学预测完全缓解的验证集平衡准确度为80.8%,影像组学评分可将患者分为低危和高危组(5年总生存率95.5%对36.4%,p<0.001)。
要点
- 257例局部晚期宫颈癌患者按3:1随机分为训练集和验证集,提取254个影像组学特征。
- 临床病理参数联合影像组学预测完全缓解的验证集平衡准确度为80.8%。
- 影像组学评分可将患者分为低危和高危组,5年总生存率分别为95.5%和36.4%(p<0.001)。
核心结论
- 结合临床病理参数与基于CT的影像组学可能对预测局部晚期宫颈癌的临床终点有价值;若经验证,该模型可能指导治疗策略以优化疗效并减少毒性或治疗。
研究设计与样本
- 回顾性队列研究,纳入湘雅医院2014至2017年接受调强放疗的257例局部晚期宫颈癌患者,按3:1比例随机分为训练集和验证集。
- 从大体肿瘤体积、骨盆和骶椎分别提取254个影像组学特征,采用序列后向消除支持向量机算法进行特征选择和终点预测。
主要发现
- 10个临床病理参数联合34个影像组学特征预测完全缓解的验证集平衡准确度为80.8%。
- 54个影像组学特征预测总生存的验证集平衡准确度为85.8%,其评分可将患者分为低危和高危组,5年总生存率分别为95.5%和36.4%(p<0.001)。
- 临床和影像组学模型也可预测贫血和白细胞减少,验证集平衡准确度分别为71.0%和69.9%。
关键数值与推荐
- 完全缓解预测模型:10个临床病理参数联合34个影像组学特征,验证集平衡准确度80.8%。
- 总生存预测模型:54个影像组学特征,验证集平衡准确度85.8%,评分分层低危组5年总生存率95.5%对高危组36.4%(p<0.001)。
- 贫血预测模型验证集平衡准确度71.0%,白细胞减少预测模型验证集平衡准确度69.9%。
临床怎么用
- 原文结论指出结合临床病理参数与CT影像组学可能对预测局部晚期宫颈癌临床终点有价值;若经验证,该模型可能指导治疗策略以优化疗效并减少毒性或治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated whether radiomic features extracted from planning computed tomography (CT) scans predict clinical end points in patients with locally advanced cervical cancer (LACC) undergoing intensity-modulated radiation therapy and brachytherapy. DESIGN: A retrospective cohort study. SETTING: Xiangya Hospital of Central South University, Changsha, Hunan, China. POPULATION: Two hundred and fifty-seven LACC patients who were treated with intensity-modulated radiotherapy from 2014 to 2017. METHODS: Patients were allocated into the training/validation sets (3:1 ratio) using proportional random sampling, resulting in the same proportion of groups in the two sets. We extracted 254 radiomic features from each of the gross target volume, pelvis and sacral vertebrae. The sequentially backward elimination support vector machine algorithm was used for feature selection and end point prediction. MAIN OUTCOMES AND MEASURES: Clinical end points include tumour complete response (CR), 5-year overall survival (OS), anaemia, and leucopenia. RESULTS: A combination of ten clinicopathological parameters and 34 radiomic features performed best for predicting CR (validation balanced accuracy: 80.8%). The validation balanced accuracy of 54 radiomic features was 85.8% for OS, and their scores can stratify patients into the low-risk and high-risk groups (5-year OS: 95.5% versus 36.4%, p < 0.001). The clinical and radiomic models were also predictive of anaemia and leucopenia (validation balanced accuracies: 71.0% and 69.9%). CONCLUSION: This study demonstrated that combining clinicopathological parameters with CT-based radiomics may have value for predicting clinical end points in LACC. If validated, this model may guide therapeutic strategy to optimise the effectiveness and minimise toxicity or treatment for LACC.
引用
- Ren K, Shen L, Qiu J, et al. Treatment planning computed tomography radiomics for predicting treatment outcomes and haematological toxicities in locally advanced cervical cancer treated with radiotherapy: A retrospective cohort study. BJOG. 2022. PMID: 36056595. doi:10.1111/1471-0528.17285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。